HHS' "Operation Restore Trust" anti-fraud initiative may be implemented nationally.
This article was originally published in The Gray Sheet
Executive SummaryHHS "OPERATION RESTORE TRUST" MEDICARE ANTI-FRAUD EFFORT YIELDS $31 MIL. in fines, recoveries and civil monetary penalties in its first six months of existence. The penalties are the result of investigations of Medicare fraud and abuse in the areas of durable medical equipment, home health, and skilled nursing facilities.
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.
Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.